The Clinical Performance of Two Dentine Replacement Materials in Deep Occlusal Cavities (Randomized)
NCT ID: NCT06924047
Last Updated: 2025-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
50 participants
INTERVENTIONAL
2025-04-30
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of Short Fiber Reinforced Flowable Resin Composite Restorations 2y RCT
NCT04720638
Aesthetic Performance of Two Injectable Resin Composites in Class V Cavities: A Randomized Clinical Trial
NCT06950762
Bioactive Versus Non-Bioactive Restorative System in Deep Carious Molars
NCT06348953
Clinical Performance and Wear Resistance of Two Nano Ceramic Resin Composite in Class I Cavities
NCT04738604
Partial Caries Removal in Permanent Molars Restored Using Giomer
NCT06601972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bioactive injectable composite
bioactive injectable composite placed as a dentine substitute
Beautifil Flow Plus X
Shofu's Beautifil Flow Plus X F00 a advanced bioactive injectable composite
Short fiber reinforced composite
Short fiber reinforced composite added as a dentine substitute
EverX Flow
Short fiber reinforced composite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beautifil Flow Plus X
Shofu's Beautifil Flow Plus X F00 a advanced bioactive injectable composite
EverX Flow
Short fiber reinforced composite
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Medically free
3. Good oral hygiene (Plaque index ≤2 (Moderate accumulation with plaque in the sulcus))
4. Patients accepting to participate in the study.
5. Teeth of normal appearance and morphology
6. Maxillary and mandibular molar teeth with deep class Ⅰ carious lesions extending into the inner third of dentin.
Exclusion Criteria
2. Teeth with proximal lesions.
3. Patients with bad oral hygiene (Plaque index \>2).
4. Systematic disease that may interfere with the study.
5. Patients with xerostomia.
6. Presence of any abnormal occlusal habits (bruxism, nail biting, clenching).
7. Patients undergoing or will start orthodontic treatment.
8. Pregnancy.
9. Teeth with signs or symptoms of irreversible pulpitis.
10. Non-vital, fractured or cracked teeth.
11. Teeth with secondary caries.
12. Periodontally compromised teeth.
20 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dalia Sameh Fawzi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Sameh Fawzi
Principle Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Yao Y, Luo A, Hao Y. Selective versus stepwise removal of deep carious lesions: A meta-analysis of randomized controlled trials. J Dent Sci. 2023 Jan;18(1):17-26. doi: 10.1016/j.jds.2022.07.021. Epub 2022 Aug 21.
Schwendicke F, Frencken JE, Bjorndal L, Maltz M, Manton DJ, Ricketts D, Van Landuyt K, Banerjee A, Campus G, Domejean S, Fontana M, Leal S, Lo E, Machiulskiene V, Schulte A, Splieth C, Zandona AF, Innes NP. Managing Carious Lesions: Consensus Recommendations on Carious Tissue Removal. Adv Dent Res. 2016 May;28(2):58-67. doi: 10.1177/0022034516639271.
Rusnac ME, Gasparik C, Irimie AI, Grecu AG, Mesaros AS, Dudea D. Giomers in dentistry - at the boundary between dental composites and glass-ionomers. Med Pharm Rep. 2019 Apr;92(2):123-128. doi: 10.15386/mpr-1169. Epub 2019 Apr 25.
Reis A, Carrilho M, Breschi L, Loguercio AD. Overview of clinical alternatives to minimize the degradation of the resin-dentin bonds. Oper Dent. 2013 Jul-Aug;38(4):E1-E25. doi: 10.2341/12-258-LIT. Epub 2013 Mar 25.
Qin D, Hua F, John MT. GLOSSARY FOR DENTAL PATIENT-CENTERED OUTCOMES. J Evid Based Dent Pract. 2024 Jan;24(1S):101951. doi: 10.1016/j.jebdp.2023.101951. Epub 2023 Nov 5.
Ozer F, Patel R, Yip J, Yakymiv O, Saleh N, Blatz MB. Five-year clinical performance of two fluoride-releasing giomer resin materials in occlusal restorations. J Esthet Restor Dent. 2022 Dec;34(8):1213-1220. doi: 10.1111/jerd.12948. Epub 2022 Aug 7.
Maillet C, Decup F, Dantony E, Iwaz J, Chevalier C, Gueyffier F, Maucort-Boulch D, Grosgogeat B, Le Clerc J. Selected and simplified FDI criteria for assessment of restorations. J Dent. 2022 Jul;122:104109. doi: 10.1016/j.jdent.2022.104109. Epub 2022 Mar 26.
Ikeda I, Otsuki M, Sadr A, Nomura T, Kishikawa R, Tagami J. Effect of filler content of flowable composites on resin-cavity interface. Dent Mater J. 2009 Nov;28(6):679-85. doi: 10.4012/dmj.28.679.
Hoefler V, Nagaoka H, Miller CS. Long-term survival and vitality outcomes of permanent teeth following deep caries treatment with step-wise and partial-caries-removal: A Systematic Review. J Dent. 2016 Nov;54:25-32. doi: 10.1016/j.jdent.2016.09.009. Epub 2016 Sep 21.
Elderiny HM, Khallaf YS, Akah MM, Hassanein OE. Clinical Evaluation of Bioactive Injectable Resin Composite vs Conventional Nanohybrid Composite in Posterior Restorations: An 18-Month Randomized Controlled Clinical Trial. J Contemp Dent Pract. 2024 Aug 1;25(8):794-802. doi: 10.5005/jp-journals-10024-3737.
ElAziz RHA, ElAziz SAA, ElAziz PMA, Frater M, Vallittu PK, Lassila L, Garoushi S. Clinical evaluation of posterior flowable short fiber-reinforced composite restorations without proximal surface coverage. Odontology. 2024 Oct;112(4):1274-1283. doi: 10.1007/s10266-024-00905-5. Epub 2024 Feb 23.
European Society of Endodontology (ESE) developed by:; Duncan HF, Galler KM, Tomson PL, Simon S, El-Karim I, Kundzina R, Krastl G, Dammaschke T, Fransson H, Markvart M, Zehnder M, Bjorndal L. European Society of Endodontology position statement: Management of deep caries and the exposed pulp. Int Endod J. 2019 Jul;52(7):923-934. doi: 10.1111/iej.13080.
Bijelic-Donova J, Myyrylainen T, Karsila V, Vallittu PK, Tanner J. Direct Short-Fiber Reinforced Composite Resin Restorations and Glass-Ceramic Endocrowns in Endodontically Treated Molars: A 4 -Year Clinical Study. Eur J Prosthodont Restor Dent. 2022 Nov 30;30(4):284-295. doi: 10.1922/EJPRD_2333Bijelic-Donova12.
Battancs E, Sary T, Molnar J, Braunitzer G, Skolnikovics M, Schindler A, Szabo P B, Garoushi S, Frater M. Fracture Resistance and Microleakage around Direct Restorations in High C-Factor Cavities. Polymers (Basel). 2022 Aug 25;14(17):3463. doi: 10.3390/polym14173463.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Restoring Deep Occlusal Cavity
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.